Early Dose Reduction or Discontinuation vs Maintenance Antipsychotics After First Psychotic Episode Remission
Iris E. Sommer(University Medical Center Groningen), Marieke Begemann(University Medical Center Groningen), Martijn Kikkert(Arkin), Nynke Boonstra(University Medical Center Groningen), Shiral S. Gangadin(University Medical Center Groningen), Sanne Koops(University Medical Center Groningen), Lieuwe de Haan(Amsterdam UMC Location University of Amsterdam), Frederick W. Thielen(University Medical Center Freiburg), Ben Wijnen(Trimbos Institute), Franciska de Beer(University Medical Center Groningen), Bram‐Sieben Rosema(Stenden University of Applied Sciences), Wim Veling(University Medical Center Groningen), Nico van Beveren(Erasmus MC), Jort Noorman(University Medical Center Groningen), Jim van Os(King's College London)
Cited by 16
Related Papers
The size and burden of mental disorders and other disorders of the brain in Europe 2010
|European Neuropsychopharmacology|2011|3.8k
Childhood Adversities Increase the Risk of Psychosis: A Meta-analysis of Patient-Control, Prospective- and Cross-sectional Cohort Studies
|Schizophrenia Bulletin|2012|2.4k
Cost of disorders of the brain in Europe 2010
|European Neuropsychopharmacology|2011|1.7k
Schizophrenia
|Nature Reviews Disease Primers|2015|1.1k
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
|American Journal of Psychiatry|2016|1.1k